Prognostic factors of advanced or postoperative recurrent non-small cell lung cancer targeted with immune check point inhibitors

BACKGROUND: Although immune checkpoint inhibitors (ICIs) for non-small cell lung cancer (NSCLC) have been established as one of standard therapy, the prognostic factors of ICIs remain unclear, aside from the programed cell death-ligand 1 (PD-L1) expression of tumor cells. The aim of this study was t...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Thorac Dis
Main Authors: Ichiki, Yoshinobu, Taira, Akihiro, Chikaishi, Yasuhiro, Matsumiya, Hiroki, Mori, Masataka, Kanayama, Masatoshi, Nabe, Yusuke, Shinohara, Shinji, Kuwata, Taiji, Takenaka, Masaru, Oka, Soichi, Hirai, Ayako, Imanishi, Naoko, Yoneda, Kazue, Kuroda, Koji, Fujino, Yoshihisa, Tanaka, Fumihiro
Formato: Artigo
Idioma:Inglês
Publicado em: AME Publishing Company 2019
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6531735/
https://ncbi.nlm.nih.gov/pubmed/31179053
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jtd.2019.04.41
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados